Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Juan Rondán-Murillo"'
Autor:
Alejandro Diego-Nieto, Jean C. Núñez, Gema Miñana, Ignacio J. Amat-Santos, Pablo Salinas-Sanguino, Mohsen Mohandes, Ander Regueiro, Manuel Pan, Javier Lacunza, Juan Caballero-Borrego, José Antonio Fernández-Díaz, Agustín Fernández Cisnal, Sandra Santos-Martínez, Nieves Gonzalo, Beatriz Vaquerizo, Fernando Rivero, Alfonso Jurado-Román, José Abellán-Huerta, Eva Rumiz González, Juan Rondán-Murillo, María López Benito, Juan Carlos Astorga Burgo, Jesús Jiménez Mazuecos, Francisco Bosa Ojeda, Cristina Moreno-Ambroj, Manel Sabaté, Soledad Ojeda, Raúl Valdesuso Aguilar, Manuel López Pérez, Juan Sanchis, Alberto Campo-Prieto, Javier Escaned, Javier Goicolea, Javier Martín-Moreiras
Publikováno v:
Revista Española de Cardiología. 76:253-260
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce0717c4885c17465fed1922efc6052d
https://doi.org/10.1016/j.recesp.2022.05.021
https://doi.org/10.1016/j.recesp.2022.05.021
Autor:
Alberto Cordero, Mª. Rosa Fernández Olmo, Gustavo A. Cortez Quiroga, Cesar Romero‐Menor, Lorenzo Fácila, José Seijas‐Amigo, Juan Rondán Murillo, Miriam Sandin, Moisés Rodríguez‐Mañero, María C. Bello Mora, Alfonso Valle, Aisa Fornovi, Roman Freixa Pamias, Jordi Bañeras, Pedro Blanch García, María Milagros Clemente Lorenzo, Sergio Sánchez‐Álvarez, Luis López‐Rodríguez, José R. González‐Juanatey
Publikováno v:
European Journal of Clinical Investigation. 52
Monoclonal antibodies that inhibit the proprotein convertase subtilisin/kexin type 9 (PCSK9) reduce low-density lipoprotein cholesterol (LDLc) by 55%, regardless of baseline treatments. Nonetheless, the effect of other lipid parameters, such as chole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c12d677d01d1077dfc9fa8b223f85fb9
https://doi.org/10.1111/eci.13863
https://doi.org/10.1111/eci.13863
Autor:
José Seijas-Amigo, Alberto Cordero, Rosa F. Olmo, Gustavo A. Cortez Quiroga, Lorenzo Fácila, Ángel Salgado-Barreira, Francisco Reyes-Santías, Cesar Romero-Menor, Juan Rondán Murillo, Moisés Rodríguez-Mañero, María C. Bello Mora, Alfonso Valle, Miriam Sandin, Roman Freixa Pamias, Jordi Bañeras, Pedro Blanch García, Milagros Clemente Lorenzo, Sergio Sánchez-Alvarez, Luis López-Rodríguez, José R. González-Juanatey
Publikováno v:
Journal of cardiovascular pharmacology. 81(1)
Low-density lipoprotein cholesterol (LDLc) is the lead effector of atherosclerosis and main treatment target. Bempedoic acid is a novel oral drug in the therapeutic armamentarium which is able to reduce LDLc. The objectives of this study were (1) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5758aa8fcd5dc291262ba7930a60066f
https://pubmed.ncbi.nlm.nih.gov/36219195
https://pubmed.ncbi.nlm.nih.gov/36219195
Autor:
María Isabel Barrionuevo-Sánchez, Jesús Jiménez-Mazuecos, Arsenio Gallardo-López, Ricardo Sanz-Ruiz, Iñigo Lozano, Allan Rivera Juárez, Antonio Gutiérrez-Díez, Jaime Elízaga, Enrique Gutiérrez Ibañes, José M. Vegas-Valle, Beatriz Samaniego-Lampón, Leonel Díaz, Driss Melehi, Juan G. Córdoba-Soriano, Juan Rondán-Murillo
Publikováno v:
Revista Española de Cardiología (English Edition). 70:535-542
The exponential increase in coronary interventions plus the generalization of the radial approach represent the ideal scenario for starting outpatient angioplasty programs with the aim of reducing the costs while maintaining safety. This article repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b10578906f1aa21027377151824db0
https://doi.org/10.1016/j.rec.2017.01.022
https://doi.org/10.1016/j.rec.2017.01.022
Publikováno v:
Medicina Clínica. 123:156b-157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::300d25de658f247c6c480908509dead9
https://doi.org/10.1157/13064114
https://doi.org/10.1157/13064114